Nachrichten

Protection from Corona: Experience is not always an advantage with the immune system

Why the SARS-CoV2 vaccination works poorly, especially in older people, is unclear. A research team of the Institute of Immunology and the Cluster of Excellence PMI shows: A good vaccination response relies on naive immune cells, pre-existing memory cells are rather detrimental.

Link to the news: Precision Medicine in Chronic Inflammation (PMI)

Immunogenic cell death in cancer- review from Dieter Adam and colleagues in Nature Reviews Cancer
12.03.2024
Most metastatic...
New cell therapy for type 1 Diabetes
20.02.2024
The groups...
Petra Bacher awarded the Georges Köhler Prize 2023
27.09.2023
The German...
Schleswig-Holstein funds four new professorships of excellence in inflammation research
19.09.2023
The state’s...
New DFG funded Transregio on regulatory T cells
01.01.2023
The TRR...
Protection from Corona: Experience is not always an advantage with the immune system
14.08.2022
Warum die...
ERC Starting Grant
10.01.2022
1.5 million...
New Collaborative Research Center
01.01.2022
Three groups...
New pathomechanism for sarcoidosis
15.12.2021
The group...